About Medivolve Company

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. It offers investors a diversified investment in the COVID-19 medical space across the following areas; prevention, detection, and treatment. The company was founded on November 8, 2005 and is headquartered in Toronto, Canada.